image
Aptose Biosciences Inc. APTO
Healthcare - Biotechnology - NASDAQ - CA
Watchlist
$ 0.3649
-4.23 %
$ 7.12 M
Market Cap
-0.09
P/E
CASH FLOW STATEMENT
-44.6 M OPERATING CASH FLOW
-37.96%
Growth Rates
1Year -37.96%
3Years -9.58%
5Years -13.95%
7Years -20.30%
10Years -18.94%
9.96 M INVESTING CASH FLOW
-66.87%
Growth Rates
1Year -66.87%
3Years -7.61%
5Years 283.54%
7Years 6.99%
10Years 11.56%
6.91 M FINANCING CASH FLOW
5856.90%
Growth Rates
1Year 5856.90%
3Years -51.02%
5Years -24.34%
7Years 3.00%
10Years -15.03%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Aptose Biosciences Inc.
image
Net Income -51.2 M
Depreciation & Amortization 466 K
Capital Expenditures -29 K
Stock-Based Compensation 3.65 M
Change in Working Capital 2.45 M
Others 2.5 M
Free Cash Flow -44.6 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 May-2014 May-2013 May-2012 May-2011 May-2010 May-2009 May-2008 May-2007 May-2006 May-2005 May-2004 May-2003 May-2002 May-2001 May-2000 May-1999 May-1998 May-1997
OPERATING CASH FLOW
Net Income (51.2) (41.8) (65.4) (55.2) (26.3) (28.9) (11.7) (13.9) (10.5) (11.5) (9.7) (5.4) (4.5) (5.2) 5.1 (8.1) (6.4) (9.0) (16.3) (17.6) (22.2) (12.1) (8.8) (9.9) (5.7) (3.1) (3.2) (3.5)
Depreciation & Amortization 0.5 0.5 0.6 0.6 0.6 87 K 84 K 0.1 69.2 K 32.6 K 19.4 K 36.9 K 42.7 K 57.3 K 81.5 K 0.2 0.3 1.1 2.2 1.9 1.6 1.5 2.4 2.4 1.8 0.3 0.3 0.4
Deferred Income Tax 0 0 7 K 8 K 23 K 25 K 7 K 0.2 (0.7) 0 0.000001 0 4.5 5.2 (5.1) (0.4) 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 3.7 5.2 12.9 21.4 2.3 4.3 0.8 1.5 2.0 2.4 0 369 784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 48.9 K (0.6) 7.0 (0.4) 55 K 0.6 68 K 78.1 K (0.2) (0.3) 0.2 23.3 K (4.5) (5.2) (5.3) 2.2 (3.4) 2.3 2.6 1.7 0.1 0.5 0 1 K 0 (0.1) 68.7 K 0
Change in Working Capital 2.4 4.3 1.5 (0.3) 1.9 0.7 0.5 (0.1) 0.2 (0.5) 12.9 K 50.5 K 1.6 (1.5) 1.6 (0.9) (0.8) (0.3) (0.4) (0.9) 94.9 K 1.5 (1.4) 1.2 0.4 0.5 0 0.5
Cash From Operations (44.6) (32.3) (43.3) (33.9) (21.6) (23.2) (10.3) (12.2) (9.1) (9.9) (7.9) (4.9) (2.3) (6.0) (3.5) (6.6) (10.3) (5.9) (11.9) (14.9) (20.6) (8.7) (7.8) (6.3) (3.6) (2.4) (3.0) (2.6)
INVESTING CASH FLOW
Capital Expenditures 29 K 24 K (0.2) 79 K (0.1) (0.3) 13 K 3.72 K (0.2) (0.3) 20.3 K 0 0 8.19 K 1.9 K (0.2) 58 K 19 K 68 K (0.5) (0.3) (0.9) (0.3) (0.1) (3.8) 0 (0.1) 0
Other Items 10.0 30.1 (35.0) 12.7 (17.3) 0.3 (0.7) 6.2 5.9 (7.2) (10.1) 29.1 K 29 0.3 0.2 5.8 4.2 (5.0) 11.9 5.6 (1.1) 9.1 6.1 (26.3) (0.3) (5.3) 2.8 (5.7)
Cash From Investing Activities 10.0 30.1 (35.2) 12.6 (17.4) 12 K (0.7) 6.2 5.7 (7.5) (10.1) 29.1 K 29 0.2 0.2 5.6 4.2 (5.0) 11.8 5.1 (1.3) 8.1 5.8 (26.4) (4.1) (5.3) 2.7 (5.7)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 0 0 0.6 0.6 0 0.9 (1.0) (3.3) 0 0 0 0 10.3 0 0 0 0 0 2.3 (2.0) 2.5
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 29 K 15 K 0.2 0.4 10.3 2.2 13.2 (4.7) 0.8 9.5 4.4 (0.7) 2.91 K 49.9 K 0.969 0 (0.3) (1.2) 0 6.39 K 0 (0.2) 0 0 6.3 0 2.0 0
Cash From Financing Activities 6.9 0.1 0.2 58.8 103.4 27.9 13.7 5.6 0.7 10.1 35.2 5.2 1.8 6.0 (1.2) 3.5 7.4 9.7 0 11.2 22.1 0.3 0.9 1.3 40.8 7.1 2.0 7.6
CHANGE IN CASH
Net Change In Cash (27.7) (2.1) (78.3) 37.6 64.5 4.7 2.7 (0.6) (2.1) 17.2 17.2 0.3 (0.6) 0.2 (4.5) 2.5 1.3 (1.2) 76 K 1.4 0.1 (0.2) (1.1) (31.3) 33.1 (0.6) (0.3) (0.7)
FREE CASH FLOW
Free Cash Flow (44.6) (32.3) (43.5) (34.0) (21.7) (23.5) (10.3) (12.2) (9.4) (10.2) (7.9) (4.9) (2.3) (6.0) (3.5) (6.8) (10.3) (5.9) (11.9) (15.4) (20.9) (9.6) (8.1) (6.4) (7.4) (2.4) (3.2) (2.6)